1-3 of 3
Zane Kaplan, MBBS(Hons) BMedSc(Hons) PhDFRACP FRCPA
Close
Sort by
Journal Articles

Oral Rilzabrutinib, a Bruton Tyrosine Kinase Inhibitor, Showed Clinically Active and Durable Platelet Responses and Was Well-Tolerated in Patients with Heavily Pretreated Immune Thrombocytopenia

David J. Kuter, MD, Merlin Efraim, MD, Jiri Mayer, MD, Vickie McDonald, MD, Robert J. Bird, FRACP,FRCP,FRCPA,MBBS,MRCP, Thomas Regenbogen, MD, Mamta Garg, MD FRCP, FRCPath, Zane Kaplan, MBBS(Hons) BMedSc(Hons) PhDFRACP FRCPA, Olga Bandman, MD, Regan Burns, Ann Neale, Dolca Thomas, MD, Nichola Cooper, MD MRCP
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-134932
Published: 2020
Journal Articles

Gene Editing of KLF1 to Cure Sickle Cell Disease

Kevin R. Gillinder, PhD, Casie Leigh Reed, BSc, Shezlie Malelang, BSc, Helen Lorraine Mitchell, BSc, Emma Hoskin, BSc, Graham William Magor, BSc, Zane Kaplan, MBBS(Hons) BMedSc(Hons) PhDFRACP FRCPA, Andrew Charles Perkins, MBBS,PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-142339
Published: 2020
Journal Articles

The Role of Platelets in Increased Thrombogenicity Following Splenectomy: Key Platelet-Specific Receptors and Activation Markers

Sarah Luu, MBBS, Zane Kaplan, MBBS(Hons) BMedSc(Hons) PhDFRACP FRCPA, Ian J Woolley, MBBS FRACP DTMH MD, Robert K. Andrews, PhD, Claire Dendle, MBBS, FRACP, Ashwini Bennett, MBBS, BMedSci, FRACP, FRCPA, Samar Ojaimi, MBBS (Hons) FRACP FRCPA, Penelope Jones, RN
Journal: Blood
Blood (2017) 130 (Supplement 1): 4840.
https://doi.org/10.1182/blood.V130.Suppl_1.4840.4840
Published: 2017